Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP526090.RAzthEgybLB8ZoRSnLVfSe5LzsnWHDaEmRHJcEErGMsD0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP526090.RAzthEgybLB8ZoRSnLVfSe5LzsnWHDaEmRHJcEErGMsD0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP526090.RAzthEgybLB8ZoRSnLVfSe5LzsnWHDaEmRHJcEErGMsD0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP526090.RAzthEgybLB8ZoRSnLVfSe5LzsnWHDaEmRHJcEErGMsD0130_provenance.
- NP526090.RAzthEgybLB8ZoRSnLVfSe5LzsnWHDaEmRHJcEErGMsD0130_assertion description "[To improve MRD assessment by MFC, we here evaluate the combination of human Myeloid Inhibitory C-type Lectin (hMICL, also termed C-type lectin domain family 12, member A, CLEC12A) and CD 123 (also termed interleukin-3 receptor alpha, IL3RA) in combination with CD34 and CD117 (KIT), as an MRD assay in pre-clinical and clinical testing in 69 AML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526090.RAzthEgybLB8ZoRSnLVfSe5LzsnWHDaEmRHJcEErGMsD0130_provenance.
- NP526090.RAzthEgybLB8ZoRSnLVfSe5LzsnWHDaEmRHJcEErGMsD0130_assertion evidence source_evidence_literature NP526090.RAzthEgybLB8ZoRSnLVfSe5LzsnWHDaEmRHJcEErGMsD0130_provenance.
- NP526090.RAzthEgybLB8ZoRSnLVfSe5LzsnWHDaEmRHJcEErGMsD0130_assertion SIO_000772 24152218 NP526090.RAzthEgybLB8ZoRSnLVfSe5LzsnWHDaEmRHJcEErGMsD0130_provenance.
- NP526090.RAzthEgybLB8ZoRSnLVfSe5LzsnWHDaEmRHJcEErGMsD0130_assertion wasDerivedFrom befree-20150227 NP526090.RAzthEgybLB8ZoRSnLVfSe5LzsnWHDaEmRHJcEErGMsD0130_provenance.
- NP526090.RAzthEgybLB8ZoRSnLVfSe5LzsnWHDaEmRHJcEErGMsD0130_assertion wasGeneratedBy ECO_0000203 NP526090.RAzthEgybLB8ZoRSnLVfSe5LzsnWHDaEmRHJcEErGMsD0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP526090.RAzthEgybLB8ZoRSnLVfSe5LzsnWHDaEmRHJcEErGMsD0130_provenance.